【默克活動】2024默克生物科技資助專案-台灣站，正式申請開始!

【默克活動】2024默克生物科技資助專案-台灣站，正式申請開始!

好消息!  時隔五年，Advance Biotech GRANT Program 又再次來到了台灣! 默克自2014年以來在世界不同地區定期實施這些資助計畫，並在2019年首次在台灣啟動後，受到了業界的廣泛關注。「2024默克生物科技資助專案-台灣站」自6/15~8/30間，報名參加即有機會享有NTD$349萬等值的產品和服務、上游/下游和配方諮詢服務等支持，以及Emprove®高級計劃的訂閱。

活動介紹

2024默克生物科技資助專案-台灣站，正式申請開始!

好消息!  時隔五年，Advance Biotech GRANT Program又再次來到了台灣!
 
默克自2014年以來在世界不同地區定期實施這些資助計畫，並在2019年首次在台灣啟動後，受到了業界的廣泛關注。
除了幫助新興生物技術公司免費獲得產品和服務，我們希望在藥物發展的早期给予行業新興公司提供支持，
幫助他們一起開發製程，解決其遇到的各種問题，加快製程放大的速度，並推進藥物申請的流程。
我們期待在協助人類擁有更健康的未來的路途中，默克能為您貢獻一份心力!
 
別再猶豫，現在就報名參賽！
http://SigmaAldrich.com/grantprograms
 


 
【活動相關資訊】
★報名日期：6/15~8/30 止  (★7/15 前報名符合早鳥資格者，可獲紀念贈禮1份)
★報名流程：於期限內於活動網站完成「登記」及「送件」兩步驟，即報名完成
★決賽與活動頒獎日期：2024 年9月於Taiwan BioForum活動現場 (詳情另行通知)
★官方規範：https://bit.ly/45xPd6K
 
※活動詳情請上默克網站或連繫台灣默克業務喔! 敬請把握機會!

活動議程

BIOTECH RESOURCES

M Ventures

Our strategic venture capital arm globally invests in innovative ideas, driving transformation. Discover the future of healthcare and technology with us.

Open Innovation Offers

Join forces with our open innovation programs, stimulating creative solutions for humanity’s greatest challenges. Explore, innovate, and shape the future with us.

Bill & Melinda Gates Foundation

Explore the Bill & Melinda Gates Foundation’s grant opportunities. A valuable collaborator resource to solving key health and development problems worldwide.

Concept to Clinic: Bringing Your Molecule to Market

Uncover key insights from our Life Science Executive Summit, a platform for biotech innovation, funding strategies, and process development.

Emerging Biotech Executive Summit: Your Connection to Success

Unlock the potential of biotech with important excerpts from our Emerging Biotech Executive Summit. Gain insights from industry leaders and advance your molecule to market.

OUR GRANT PROGRAMS

We offer several grant programs to help biopharmaceutical and biotech start-ups, entrepreneurs, scientists, and students bring innovative ideas to the next level.

The Advance Biotech Grant Program

The Advance Biotech Grant Program is offered on a regular basis in different regions of the world. The program recognizes stand-out emerging biopharmaceutical and biotech start-ups and awards grant recipients with products, services, and consultation to advance production and help accelerate the path to commercialization. Since 2014, more than 40 biotech startups have been recognized through this Program. We are honored to support their missions as they pursue therapeutic solutions for patients suffering from cancer, brain tumors, osteoarthritis, and cardiovascular disorders. To be considered for the grant, you must describe your therapeutic focus, clinical strategy, and explain how we can help you overcome challenges and address gaps in expertise to bring your innovation across the finish line.

Apply to the 2024 Taiwan Grant Program

The Taiwan grand prize for an emerging, start-up biotech or biopharmaceutical company includes NTD 3,490,000 in products and services, and support such as upstream, downstream and formulation consultation services, and a subscription to the Emprove® Premium program.
The application cycle for the 2024 Taiwan Advance Biotech Grant Program has started! Click HERE to submit your application today!

TOP
  • Global Bio and Investment Monthly
  • 讀者服務電話：+886 2 2726 1065時間：週一 ~ 週五 09:00 ~ 18:00
  • 服務信箱：[email protected]
  • 地址：110臺北市信義區信義路六段29號2樓之一, Taiwan

我們的服務